Abstract
The purpose of this review is to revise and refine the available evidence in support of a clinical guideline for the yearly screening of sero-immunity to hepatitis B as part of ongoing follow-up therapy for patients, ages six to 20 years old, diagnosed with Inflammatory Bowel Disease and on infliximab.
Sigma Membership
Unknown
Lead Author Affiliation
Florida International University, Miami, Florida, USA
Type
Poster
Format Type
Text-based Document, Video Recording
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Hepatitis B, Inflammatory Bowel Disease, Infliximab
Recommended Citation
Martinez, Sarybeth Tirado; Miller, Audrey P.; and Goldin, Deana, "Infliximab and the effect on immunity to hepatitis B in patients with inflammatory bowel disease" (2020). INRC (Congress). 104.
https://www.sigmarepository.org/inrc/2020/posters_2020/104
Conference Name
31st International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Virtual Event
Conference Year
2020
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Infliximab and the effect on immunity to hepatitis B in patients with inflammatory bowel disease
Virtual Event
The purpose of this review is to revise and refine the available evidence in support of a clinical guideline for the yearly screening of sero-immunity to hepatitis B as part of ongoing follow-up therapy for patients, ages six to 20 years old, diagnosed with Inflammatory Bowel Disease and on infliximab.